TechCrunch | July 22, 2021, 3:27 p.m.
Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It’s another sign of snowballing interest in new approaches to drug development – a traditionally risky business. Absci focuses on speeding drug development in the preclinical stages. The company has developed and acquired a handful of tools that can predict […]Read Full Article
TechCrunch | July 24, 2021, 3 p.m.
TechCrunch | July 24, 2021, 2 p.m.
TechCrunch | July 24, 2021, 1 p.m.
FT | July 24, 2021, 12:55 p.m.